期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
牛产气荚膜梭菌病三价浓缩灭活苗免疫效力试验及免疫持续期测定
1
作者 马乐英 蒋祯 +1 位作者 蒋天梅 秦应中 《中国兽医科技》 CSCD 2000年第4期36-37,共2页
关键词 牛产气荚梭菌病 三价浓缩灭活苗 免疫效力
下载PDF
新佐剂新流二联浓缩苗与常规新流二联苗肉鸡免疫效果比较 被引量:2
2
作者 张亚 段佳蕾 +5 位作者 刘武杰 薛景景 胡小飞 田辉 张盼涛 田克恭 《中国动物传染病学报》 CAS 北大核心 2022年第2期42-47,共6页
为比较新型油佐剂鸡新城疫、禽流感(H9亚型)二联浓缩灭活疫苗(以下简称“新佐剂新流二联浓缩苗”)与常规油佐剂鸡新城疫、禽流感(H9亚型)二联灭活疫苗(以下简称“常规新流二联苗”)在商品肉鸡上的免疫效果,本研究用7日龄AA肉鸡对两种疫... 为比较新型油佐剂鸡新城疫、禽流感(H9亚型)二联浓缩灭活疫苗(以下简称“新佐剂新流二联浓缩苗”)与常规油佐剂鸡新城疫、禽流感(H9亚型)二联灭活疫苗(以下简称“常规新流二联苗”)在商品肉鸡上的免疫效果,本研究用7日龄AA肉鸡对两种疫苗的安全性和有效性进行评价。安全性评价结果表明,商品肉鸡免疫新佐剂新流二联浓缩苗和常规新流二联苗后无任何不良反应,两种疫苗对肉鸡生长无影响,但新佐剂新流二联浓缩苗使用剂量免疫后14 d疫苗即可完全吸收,而常规新流二联苗免疫后28 d疫苗才能完全吸收。效力评价结果表明,与常规新流二联苗相比,新佐剂新流二联浓缩苗免疫后抗体产生速度快、滴度高、均匀度好,免疫后7 d即可为免疫鸡提供针对NDV和H9亚型禽流感的完全攻毒保护,保护效果优于常规新流二联苗。研究结果显示,新佐剂新流二联浓缩苗在肉鸡上安全、有效,具有疫苗粘度低、免疫剂量小、抗体产生快、疫苗吸收快的优势,适合大范围应用于肉鸡。 展开更多
关键词 鸡新城疫 H9亚型禽流感 浓缩灭活苗 无铝油佐剂 粘度
下载PDF
Preparation of Purified and Inactivated HP-PRRS Vaccine
3
作者 唐艳林 宋睿 +2 位作者 李静姬 苗丽娟 何玉友 《Agricultural Science & Technology》 CAS 2014年第6期937-941,共5页
[Objective] The aim of this study was to improve the purification and protective potency of HP-PRRS inactivated vaccine. [Method] HP-PRRS virus that had been multiplied inside Marc-145 cells was collected and concentr... [Objective] The aim of this study was to improve the purification and protective potency of HP-PRRS inactivated vaccine. [Method] HP-PRRS virus that had been multiplied inside Marc-145 cells was collected and concentrated 50 times and then inactivated. Complete virions were separated and collected by chromatography with Sepharose 4 Fast Flow. Oil adjuvant was added to prepare purified inactivated vaccine. [Result] Viral protein was separated from other proteins by purification and the viral protein contents ranged from 76.7% to 82.4%, and 96% of the expected serum proteins were removed. Protective potency of purified vaccine was above 4/5 and positive conversion rate of antibody was over 86%, both higher than that of unpurified vaccine. The differences were significant. [Conclusion] The experiment il-lustrated that the immune efficacy of vaccine can be enhanced through concentrat- ing and purifying, while the non-viral protein can be removed, so that allergic reaction and stress response cadsed by vaccine inoculation can be avoided. 展开更多
关键词 HP-PRRS purified inactivated vaccine Protective potency Positive con-version rate of antibody Stress response
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部